Now in #PainReports: “Characterization of preclinical models to investigate spinal cord stimulation for neuropathic pain: a systematic review and meta-analysis” by @DaveMugan et al. https://t.co/eRo6rBNOnd
To our international customers: Congratulations to the team of @ZNA Hoge Beuken on their first implant of the Evoke® System. For anyone in the EU who would like to learn more about Evoke, please visit https://t.co/wpGFuMZUcW
Dr Ashish Gulve clinical lead consultant in pain management at #JamesCookHospital featured recently in pain management supplement.
Read more …https://t.co/5cdTzLwwPX
#HealthAwareness
Another exciting #closedloop milestone in Europe! The Saluda team would like to extend a big congratulations to Drs Katarina Landy, Anders Wahlstedt, and Terje Kirketeig as the first implanters of the Evoke® Closed-Loop Spinal Cord Stimulation (SCS) System in the Nordics. #SCS
Saluda Medical is celebrating our 8th anniversary. Thank you to those that have supported us in the journey to get here - clinicians, patients, employees, investors, business partners & countless others. We look forward to our continued partnership in our quest to transform SCS.
The UK's National Institute for Health and Care Excellence (NICE) issued a Medtech Innovation Briefing (MIB) on the Evoke Closed-Loop Spinal Cord Stimulation System.
Read more on the briefing here: https://t.co/hhvC6Rdt4g
#SCS#ChronicPain#Neuromodulation#ClosedLoopSCS
Continuing our mission to transform chronic pain treatment, Saluda announces the start of the ECAP Study – an investigational study in the U.S. to further evaluate neurophysiological measures and clinical outcomes of the Evoke® System.
BREAKING: Saluda Medical Results of the U.S. Pivotal Study through 12 Months Published in @TheLancetNeuro
Read the full release here: https://t.co/B2ehR3h4Mm
#SCS#Neuromodulation#ChronicPain
CAUTION-Investigational device. Limited by United States law to investigational use
BREAKING: Saluda Medical Secures Debt Financing From @Medtronic
Proceeds to Fund Continued Development of Evoke® #ECAP-Controlled, #ClosedLoop#SCS System
https://t.co/6sQ2O6m78Z
CAUTION--Investigational device. Limited by Federal (or United States) law to investigational use.
BREAKING: Saluda Medical Raises $75 Million Equity Financing from @bostonsci and Redmile Group
https://t.co/DXpxzwYmUi
#ClosedLoop#SCS#Neuromodulation#ECAP#ChronicPain
CAUTION--Investigational device. Limited by Federal (or United States) law to investigational use.